Previous 10 | Next 10 |
home / stock / dva / dva articles
Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...
Tuesday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary e...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quar...
Expansion would make DaVita the largest dialysis services provider in Latin America DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE:DVA), a ...
Javier Rodriguez, Chief Executive Officer at DaVita (NYSE:DVA), disclosed an insider sell on February 28, according to a recent SEC filing. What Ha...
JAMES HEARTY, Chief Compliance Officer at DaVita (NYSE:DVA), reported an insider sell on February 21, according to a new SEC filing. What Happened...
Tuesday, Fresenius Medical Care AG (NYSE:FMS) reported fourth-quarter 2023 revenue of €4.9 billion ($5.37 billion, almost in line with ...
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. Shares of Charles River Laboratories International, I...
On December 18, a recent SEC filing unveiled that Javier Rodriguez, Chief Executive Officer at DaVita (NYSE:DVA) made an insider sell. What Happene...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...